Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technetium-99m-labeled red blood cell imaging.

D Front, O Israel, D Groshar

    Seminars in Nuclear Medicine
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Strengthening incident learning in radiotherapy practice: insights from the MARLIN study.

    Clinical and translational radiation oncology·2026
    Same author

    Does injection of botulinum toxin to salivary glands require ultrasound guidance?

    International journal of pediatric otorhinolaryngology·2024
    Same author

    The XENONnT dark matter experiment.

    The European physical journal. C, Particles and fields·2024
    Same author

    Quantitative biomarkers for liver metastases: comparison of MRI diffusion-weighted imaging heterogeneity index and fluorine-18-fluoro-deoxyglucose standardised uptake value in hybrid PET/MR.

    Clinical radiology·2018
    Same author

    Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline.

    European journal of nuclear medicine and molecular imaging·2018
    Same author

    Early <sup>68</sup>GA-PSMA PET/MRI acquisition: assessment of lesion detectability and PET metrics in patients with prostate cancer undergoing same-day late PET/CT.

    Clinical radiology·2017

    Technetium-99m labeled red blood cells are effective for imaging vascular abnormalities like hemangiomas. This technique, particularly three-phase red cell scintigraphy, aids in diagnosing liver hemangiomas and other vascular lesions.

    Area of Science:

    • Nuclear Medicine
    • Radiology
    • Oncology

    Background:

    • Vascular abnormalities require accurate diagnostic imaging.
    • Hemangiomas present unique perfusion and blood pool characteristics.

    Purpose of the Study:

    • To evaluate the utility of 99mTc-labeled red blood cells for imaging vascular abnormalities.
    • To highlight the diagnostic value of "perfusion blood-pool mismatch" in hemangioma diagnosis.
    • To assess the role of red cell scintigraphy in specific clinical scenarios.

    Main Methods:

    • Utilizing Technetium-99m (99mTc) labeled red blood cells for intravascular imaging.
    • Performing three-phase 99mTc-labeled red blood cell scintigraphy.
    • Employing heat-damaged red blood cells for spleen imaging.

    Related Experiment Videos

    Main Results:

    • 99mTc-labeled red blood cells serve as a suitable intravascular imaging agent.
    • The "perfusion blood-pool mismatch" is a key indicator for hemangioma diagnosis.
    • Red cell scintigraphy is valuable for diagnosing liver, head and neck, and skin hemangiomas, as well as venous occlusion.
    • Heat-damaged red blood cells are specific for spleen imaging.

    Conclusions:

    • Three-phase 99mTc-labeled red blood cell scintigraphy is recommended before liver biopsy for suspected cavernous hemangiomas.
    • Red cell scintigraphy aids in establishing the vascular nature of various hemangiomas and diagnosing venous occlusion.
    • Heat-damaged red blood cell imaging is beneficial for equivocal splenic pathology cases.